Discovery of the Antitumor Effects of a Porphyrazine Diol (Pz 285) in MDA-MB-231 Breast Tumor Xenograft Models in Mice.

about

Discovery of the Antitumor Effects of a Porphyrazine Diol (Pz 285) in MDA-MB-231 Breast Tumor Xenograft Models in Mice.

Item

http://www.wikidata.org/entity/Q50431829

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Discovery of the Antitumor Eff ...... umor Xenograft Models in Mice.

@en

Discovery of the Antitumor Effects of a Porphyrazine Diol

@nl

type

Item

label

Discovery of the Antitumor Eff ...... umor Xenograft Models in Mice.

@en

Discovery of the Antitumor Effects of a Porphyrazine Diol

@nl

prefLabel

Discovery of the Antitumor Eff ...... umor Xenograft Models in Mice.

@en

Discovery of the Antitumor Effects of a Porphyrazine Diol

@nl

P1476

Discovery of the Antitumor Eff ...... Tumor Xenograft Models in Mice

@en

P2093

Andrew P Mazar

http://www.w3.org/2001/XMLSchema#string

Anthony G M Barrett

http://www.w3.org/2001/XMLSchema#string

Brian M Hoffman

http://www.w3.org/2001/XMLSchema#string

Evan R Trivedi

http://www.w3.org/2001/XMLSchema#string

Irawati K Kandela

http://www.w3.org/2001/XMLSchema#string

Lauren E Cochran

http://www.w3.org/2001/XMLSchema#string

P2860

Doxorubicin cardiomyopathy

Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation.

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models.

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Synthesis and characterization of new porphyrazine-Gd(III) conjugates as multimodal MR contrast agents

Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model.

Serum proteins as drug carriers of anticancer agents: a review.

Oncologic photodynamic therapy photosensitizers: a clinical review.

Future of oncologic photodynamic therapy.

Synthesis of Tumor-avid Photosensitizer-Gd(III)DTPA conjugates: impact of the number of gadolinium units in T1/T2 relaxivity, intracellular localization, and photosensitizing efficacy.

P304

705-709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.7B00063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Katherine J McAuliffe

P577

2017-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28740602

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5512131

http://www.w3.org/2001/XMLSchema#string